A double-blind, 4-block randomized, placebo-controlled, adaptive phase 2/3 trial to confirm efficacy and safety of BLS-ILB-E710c in patients with cervical intraepithelial neoplasia 2/3 with extension study

被引：0
|
作者：
Ouh, Yung-Taek [1 ]
Song, Seung Hun [2 ]
Kim, Young Tae [3 ]
Cho, Chi-Heum [4 ]
Kim, Tae Jin [5 ]
Min, Seong Su [6 ]
Lee, Do Young [6 ]
Park, Young-Chul [6 ]
Lee, Jae Kwan [7 ]
机构：
[1] Kangwon Natl Univ Hosp, Chuncheon Si, South Korea
[2] Cha Univ, CHA Bundang Med Ctr, Bundang Med Ctr, Seongnam Si, Gyeonggi Do, South Korea
[3] Yonsei Univ, Inst Womens Med Life Sci, Coll Med, Seoul, South Korea
[4] Keimyung Univ, Sch Med, Daegu, South Korea
[5] Konkuk Univ, Sch Med, Seoul, South Korea
[6] BL Corp, Yongin, South Korea
[7] Korea Univ, Guro Hosp, Coll Med, Seoul, South Korea
来源：
GYNECOLOGIC ONCOLOGY | 2023年 / 176卷
关键词：
D O I：
10.1016/j.ygyno.2023.06.208
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1304
引用
收藏
页码：S187 / S188
页数：2
相关论文
共 50 条
  • [1] A DOUBLE-BLIND, 4-BLOCK RANDOMIZED, PLACEBO-CONTROLLED, ADAPTIVE PHASE 2/3 TRIAL TO CONFIRM EFFICACY OF BLS-ILB-E710C IN PATIENTS WITH CERVICAL INTRAEPITHELIAL NEOPLASIA 2/3 WITH EXTENSION STUDY
    Lee, Jae Kwan
    Song, Seung Hun
    Kim, Young Tae
    Cho, Chi-Heum
    Kim, Tae Jin
    Min, Seong Su
    Lee, Do Young
    Park, Young-Chul
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A185 - A185
  • [2] A double-blind randomized, placebo-controlled trial of oral administration with human papillomavirus (HPV) type 16 E7-expressing Lactobacillus-based vaccine, BLS-ILB-E710c, for the treatment of cervical intraepithelial neoplasia (CIN2/3)
    Lee, Jae Kwan
    Song, Seung Hun
    Kim, Young Tae
    Cho, Chi-Heum
    Kim, Chan Joo
    Park, Young-Chul
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [3] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ANAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES
    Yang, H. K.
    Lee, S. H.
    Min, K. W.
    Park, S. W.
    Chung, C. H.
    Park, K. S.
    Choi, S. H.
    Song, K. -H.
    Kim, D. -M.
    Lee, M. -K.
    Sung, Y. A.
    Baik, S. H.
    Kim, I. J.
    Cha, B. -S.
    Park, J. H.
    Ahn, Y. B.
    Lee, I. -K.
    Yoo, S. -J.
    Kim, J. T.
    Park, I. B.
    Park, T. S.
    Yoon, K. -H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S149 - S150
  • [4] Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial
    Ji, Linong
    Lu, Jinmiao
    Gao, Leili
    Ying, Changjiang
    Sun, Jiao
    Han, Jie
    Zhao, Wenhua
    Gao, Yunming
    Wang, Kun
    Zheng, Xin
    Xie, Daosheng
    Ding, Juping
    Zhao, Jiahong
    Yu, Qiang
    Wang, Tong
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3671 - 3681
  • [5] Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis
    Leber, Andrew
    Hontecillas, Raquel
    Juni, Nuria Tubau
    Bassaganya-Riera, Josep
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S821 - S821
  • [6] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CHIGLITAZAR IN NASH PATIENTS
    You, Hong
    Sun, Yameng
    Wu, Cuisong
    Xin, Guijie
    Zhong, Bihui
    Wu, Xiaofeng
    Liu, Yali
    Shi, Junping
    Zhang, Qin
    Zhao, Yingren
    Gao, Yufeng
    Xin, Yongning
    Zhu, Yueyong
    Wu, Lixian
    Mao, Xiaorong
    Du, Jian
    Shang, Jia
    Sun, Weiwei
    Xu, Jie
    Yu, Zujiang
    Nan, Yuemin
    Sheng, Huiping
    Li, Yue
    Rao, Huiying
    Yu, Chaohui
    Wu, Xiaoning
    Tong, Xiaofei
    HEPATOLOGY, 2024, 80 : S1969 - S1970
  • [7] Safety and efficacy of ataluren in nmDMD patients from Study 041, a phase 3, randomized, double-blind, placebo-controlled trial
    McDonald, C.
    Wu, S.
    Gulati, S.
    Komaki, H.
    Ruiz-Garcia, M.
    Kostera-Pruszczyk, A.
    Vlodavets, D.
    Chae, J.
    Jong, Y.
    Karachunski, P.
    Statland, J.
    Lorentzos, M.
    Penematsa, V
    Chou, C.
    Lin, M.
    Werner, C.
    Trifillis, P.
    Gordon, G.
    Klein, M.
    NEUROMUSCULAR DISORDERS, 2022, 32
  • [8] Safety and Efficacy of Ataluren in nmDMD Patients from Study 041, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
    McDonald, Craig M.
    Wu, Shiwen
    Gulati, Sheffali
    Komaki, Hirofumi
    Escobar, Rosa E.
    Kostera-Pruszczyk, Anna
    Vlodavets, Dmitry
    Chae, Jong-Hee
    Jong, Yuh-Jyh
    Karachunski, Peter
    Statland, Jeffrey
    Lorentzos, Michelle
    Penematsa, Vinay
    Chou, Connie
    Lin, Min
    Werner, Christian
    Trifillis, Panayiota
    Gordon, Gregory
    Koladicz, Karyn
    Mastrandrea, Nicholas
    Klein, Matthew
    NEUROLOGY, 2023, 100 (17)
  • [9] Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Patients: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
    Zhang, Xiao
    Xu, Huji
    Zhang, Zhiyi
    Li, Yang
    Pauer, Lynne
    Liao, Shanmei
    Xu, Gaiping
    Zhang, Fengchun
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
    Hassanien, M.
    Moshrif, A.
    Hetta, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 34 - 35
12345